France has had no request for investment approval in biotech Abivax - official
12/01/2026 14:37
PARIS, Jan 12 (Reuters) - France's finance ministry has received no request seeking investment approval in Abivax ABVX.PA and has had no contact with Eli Lilly LLY.N, a ministry official said on Monday, following media reports that the U.S. pharma giant was still interested in buying the French biotech firm. (Reporting by Mathieu Rosemain, writing by Louise Rasmussen, editing by Benoit Van Overstraeten) ((Louisebreusch.rasmussen@tr.com; +45 21 27 97 79;))
Recent news on Abivax SA
See all newsAbivax shares fall after rival drug data, trader says
France's Abivax H1 net loss widens on higher expenses driven by clinical programs
U.S. RESEARCH ROUNDUP-Caseys General Stores, Targa Resources, United Rentals
GS starts Abivax at 'buy,' sees multibillion sales potential for lead drug candidate
Europe's STOXX 600 ends week at all-time high on earnings support, soft US jobs data